Beijing Tiantan Biological Products Corp Ltd (600161) — Financial Flexibility Index
Beijing Tiantan Biological Products Corp Ltd (600161) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥443.87 Million (operating CF CN¥318.80 Million minus capex CN¥125.07 Million) represents 0% of total liabilities (CN¥1.60 Billion). Check total reinvestment intensity of Beijing Tiantan Biological Products Corp to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Tiantan Biological Products Corp Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. For the full cash flow conversion analysis, see Beijing Tiantan Biological Products Corp cash flow conversion.
Annual Financial Flexibility Index for Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Beijing Tiantan Biological Products Corp Ltd. Explore 600161 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | CN¥1.89 Billion | CN¥819.78 Million | CN¥1.34 Billion | ▼ -41.7% |
| 2023 | 2.42x | CN¥3.47 Billion | CN¥2.39 Billion | CN¥1.43 Billion | ▲ +54.7% |
| 2022 | 1.57x | CN¥2.48 Billion | CN¥1.13 Billion | CN¥1.58 Billion | ▼ -2.9% |
| 2021 | 1.61x | CN¥2.11 Billion | CN¥980.35 Million | CN¥1.31 Billion | ▲ +85.6% |
| 2020 | 0.87x | CN¥1.31 Billion | CN¥702.11 Million | CN¥1.51 Billion | ▼ -15.5% |
| 2019 | 1.03x | CN¥1.17 Billion | CN¥642.47 Million | CN¥1.14 Billion | ▼ -23.8% |
| 2018 | 1.35x | CN¥971.82 Million | CN¥677.92 Million | CN¥720.19 Million | ▲ +78.8% |
| 2017 | 0.75x | CN¥363.26 Million | CN¥218.39 Million | CN¥481.46 Million | ▲ +295.4% |
| 2016 | 0.19x | CN¥637.77 Million | CN¥428.37 Million | CN¥3.34 Billion | ▼ -16.3% |
| 2015 | 0.23x | CN¥773.83 Million | CN¥473.26 Million | CN¥3.40 Billion | ▼ -8.1% |
| 2014 | 0.25x | CN¥942.11 Million | CN¥477.95 Million | CN¥3.80 Billion | ▼ -23.0% |
| 2013 | 0.32x | CN¥1.11 Billion | CN¥566.43 Million | CN¥3.46 Billion | ▼ -1.4% |
| 2012 | 0.33x | CN¥989.88 Million | CN¥432.00 Million | CN¥3.03 Billion | ▼ -45.8% |
| 2011 | 0.60x | CN¥1.07 Billion | CN¥353.15 Million | CN¥1.78 Billion | ▲ +63.2% |
| 2010 | 0.37x | CN¥482.39 Million | CN¥184.85 Million | CN¥1.31 Billion | ▼ -30.0% |
| 2009 | 0.53x | CN¥639.39 Million | CN¥448.23 Million | CN¥1.21 Billion | ▼ -45.7% |
| 2008 | 0.97x | CN¥426.70 Million | CN¥276.39 Million | CN¥439.35 Million | ▲ +63.1% |
| 2007 | 0.60x | CN¥219.95 Million | CN¥153.55 Million | CN¥369.34 Million | ▼ -6.1% |
| 2006 | 0.63x | CN¥225.86 Million | CN¥154.36 Million | CN¥356.20 Million | ▼ -33.6% |
| 2005 | 0.95x | CN¥171.47 Million | CN¥131.69 Million | CN¥179.67 Million | ▼ -38.8% |
| 2004 | 1.56x | CN¥196.00 Million | CN¥110.11 Million | CN¥125.70 Million | ▲ +62.3% |
| 2003 | 0.96x | CN¥152.95 Million | CN¥62.93 Million | CN¥159.24 Million | ▲ +73.8% |
| 2002 | 0.55x | CN¥119.21 Million | CN¥84.38 Million | CN¥215.73 Million | ▲ +0.4% |
| 2001 | 0.55x | CN¥95.58 Million | CN¥46.49 Million | CN¥173.64 Million | ▼ -0.2% |
| 2000 | 0.55x | CN¥91.94 Million | CN¥47.90 Million | CN¥166.77 Million | ▲ +2.6% |
| 1999 | 0.54x | CN¥85.92 Million | CN¥42.58 Million | CN¥159.88 Million | ▼ -25.6% |
| 1998 | 0.72x | CN¥81.32 Million | CN¥23.71 Million | CN¥112.54 Million | — |